Increased concentrations of soluble tumour necrosis factor receptor (sTNFR) I and II in peritoneal fluid from women with endometriosis

Molecular Human Reproduction

Volumn 6, Issue 10, 2000, Pages 929-933

  Koga, Kaori ^a   Osuga, Yutaka ^a   Tsutsumi, Osamu ^a,b   Okagaki, Ryugo ^a   Momoeda, Mikio ^a   Yano, Tetsu ^a   Fujiwara, Toshihiro ^a   Takai, Yasushi ^a   Kugu, Koji ^a   Morita, Yutaka ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Endometriosis; Infertility; Peritoneal fluid; Soluble TNF receptor; TNF

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PERITONEAL FLUID; PRIORITY JOURNAL;

EID: 0033808528     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/6.10.929     Document Type: Article

References (48)

1. Revised American Fertility Society classification of endometriosis: 1985
2. Soluble receptors for tumor necrosis factor: Occurrence in association with normal delivery at term
3. Seminars in medicine of the Beth Israel Hospital, Boston: The tumor necrosis factor ligand and receptor families
4. An inverse relation between the expression of tumor necrosis factor alpha (TNF-alpha) and TNF-alpha receptor in human endometrium
5. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation
6. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis
7. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
8. Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis
9. TNF-receptors on human peritoneal mesothelial cells: Regulation of receptor levels and shedding by IL-1 alpha and TNF alpha
10. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery
11. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis
12. Status of current research on endometriosis
13. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein
14. Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro
15. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro
16. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease
17. Detection of apoptosis in human endometriotic tissues
18. Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis
19. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors
20. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis
21. Peritoneal cellular immunity and endometriosis
22. Expression and regulation of the tumour necrosis factor-alpha gene in the female reproductive tract
23. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium
24. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage- conditioned media of women with endometriosis
25. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis
26. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
27. Mitogen(s) for endometrial-like cells can be detected in human peritoneal fluid
28. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms
29. Slow release of soluble TNF receptors by monocytes in vitro
30. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
31. Biology of the interleukin-2 receptor
32. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer
33. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle
34. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis
35. Immunological evidence for a human ovarian tumor necrosis factor-alpha
36. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity
37. Pattern of soluble TNF receptors I and II in sepsis
38. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos
39. Inflammatory cytokines in peritoneal fluid of women with endometriosis
40. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade
41. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling
42. Tumour necrosis factor-alpha-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/beta-catenin and disassembly of actin filaments
43. Distinct regional and menstrual cycle dependent distribution of apoptosis in human endometrium. Potential regulatory role of T cells and TNF-α
44. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase- specific production of TNF alpha in human endometrium
45. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis
46. Tumor necrosis factor in plasma and peritoneal fluid of women with and without endometriosis
47. Tumour necrosis factor-α (TNF-α) in human endometriumand uterine secretion: An evaluation by immunohistochemistry, ELISA and semiquantitative RT-PCR
48. Cytokine involvement in oocytes and early embryos